These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21755593)

  • 1. Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma.
    Al-Tahan A; Sarkis O; Harajly M; Baghdadi OK; Zibara K; Boulos F; Dighe D; Kregel S; Bazarbachi A; El-Sabban M; Skapek SX; Saab R
    Pediatr Blood Cancer; 2012 Jun; 58(6):877-84. PubMed ID: 21755593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of rhabdomyosarcoma cell lines using retinoic acid.
    Barlow JW; Wiley JC; Mous M; Narendran A; Gee MF; Goldberg M; Sexsmith E; Malkin D
    Pediatr Blood Cancer; 2006 Nov; 47(6):773-84. PubMed ID: 16283617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of human rhabdomyosarcoma cell lines to retinoic acid: relationship with induction of differentiation and retinoic acid sensitivity.
    Ricaud S; Vernus B; Bonnieu A
    Exp Cell Res; 2005 Dec; 311(2):192-204. PubMed ID: 16236281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the level of gamma-glutamyltranspeptidase activity on the response of poorly and moderately differentiated rhabdomyosarcoma cell lines to all-trans-retinoic acid.
    Palomares T; Castro B; del Olmo M; Iglesias A; Bilbao P; Alonso-Varona A
    Anticancer Drugs; 2006 Nov; 17(10):1127-39. PubMed ID: 17075312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
    J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.
    Basma H; Ghayad SE; Rammal G; Mancinelli A; Harajly M; Ghamloush F; Dweik L; El-Eit R; Zalzali H; Rabeh W; Pisano C; Darwiche N; Saab R
    Int J Cancer; 2016 Mar; 138(6):1528-37. PubMed ID: 26453552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
    Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
    Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation therapy exerts antitumor effects on stem-like glioma cells.
    Campos B; Wan F; Farhadi M; Ernst A; Zeppernick F; Tagscherer KE; Ahmadi R; Lohr J; Dictus C; Gdynia G; Combs SE; Goidts V; Helmke BM; Eckstein V; Roth W; Beckhove P; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende C
    Clin Cancer Res; 2010 May; 16(10):2715-28. PubMed ID: 20442299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
    Crouch GD; Kalebic T; Tsokos M; Helman LJ
    Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the NF-kappa B inhibitors curcumin and lactacystin on myogenic differentiation of rhabdomyosarcoma cells.
    Berger F; Büchsler I; Munz B
    Differentiation; 2012 Jun; 83(5):271-81. PubMed ID: 22469857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
    Crouch GD; Helman LJ
    Cancer Res; 1991 Sep; 51(18):4882-7. PubMed ID: 1893378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
    Cinatl J; Cinatl J; Michaelis M; Kabickova H; Kotchetkov R; Vogel JU; Doerr HW; Klingebiel T; Driever PH
    Cancer Res; 2003 Apr; 63(7):1508-14. PubMed ID: 12670897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
    Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
    Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle.
    Saab R; Spunt SL; Skapek SX
    Curr Top Dev Biol; 2011; 94():197-234. PubMed ID: 21295688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysis.
    Ramp U; Gerharz CD; Engers R; Marx N; Gabbert HE
    Anticancer Res; 1995; 15(1):181-8. PubMed ID: 7733631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Targeting of Myoblast Fusogenic Signaling and Differentiation-Arrest Antagonizes Rhabdomyosarcoma Cells.
    Granados VA; Avirneni-Vadlamudi U; Dalal P; Scarborough SR; Galindo KA; Mahajan P; Galindo RL
    Cancer Res; 2019 Sep; 79(18):4585-4591. PubMed ID: 31331911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
    Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
    Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer.
    Huss WJ; Lai L; Barrios RJ; Hirschi KK; Greenberg NM
    Prostate; 2004 Oct; 61(2):142-52. PubMed ID: 15305337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.